Chlorogenic Acid Alleviates Experimental Asthma by Reprogramming DHA Metabolism to Inhibit Ferroptosis
International Journal of Molecular Sciences · 25.05.2026 · 27 (11) · 4747
DOI: 10.3390/ijms27114747 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.05.2026. Verfasst von Ping Zhou und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China. Hauptthemen laut MEDLINE: Ferroptosis, Asthma, Chlorogenic Acid, Docosahexaenoic Acids. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basic research business fund project of public welfare research institutes in Xinjiang Uygur Autonomous Region, Fundamental Research Funds for the Central Universities, Major Consulting Project of the Chinese Academy of Engineering.
Abstract (Originalsprache)
Asthma is a chronic inflammatory disease with limited therapeutic options, highlighting the urgent need to explore alternative mechanisms and agents. Chlorogenic acid (CGA), a dietary polyphenol, exhibits anti-asthmatic properties, but its precise molecular mechanisms remain poorly understood. This study aimed to elucidate the mechanistic basis of CGA’s anti-asthmatic effects, hypothesizing a central role in regulating polyunsaturated fatty acid metabolism and ferroptosis. An ovalbumin-induced murine asthma model was established in female BALB/c mice to evaluate the therapeutic efficacy of CGA through inflammatory cell counts, cytokine levels (ELISA), and lung histopathology. Integrated lung lipidomics (LC-MS/MS) was employed to profile lipid mediators and phospholipids. The underlying mechanism was investigated in erastin-induced ferroptosis in BEAS-2B cells and validated in mouse lung tissue using qPCR, immunofluorescence, and assays for reactive oxygen species (ROS) and Fe2+. CGA treatment significantly attenuated airway inflammation, reduced Th2 cytokine (IL-4, IL-5) and IgE levels, and ameliorated lung pathology in a dose-dependent manner. Lipidomics revealed that asthma was associated with dysregulated docosahexaenoic acid (DHA) metabolism, characterized by elevated pro-inflammatory lipid peroxidation products (e.g., 11-HDoHE, 14-HDoHE), a profile reversed by CGA intervention. Mechanistically, molecular docking and subsequent validation identified CGA as an activator of the Nrf2 antioxidant pathway, leading to upregulation of the key ferroptosis defense genes SLC7A11 and GPX4 both in vitro and in vivo. Consequently, CGA treatment suppressed erastin-induced ROS production and Fe2+ accumulation in BEAS-2B cells. In conclusion, this study demonstrates that CGA exerts anti-asthmatic effects by reprogramming DHA metabolism to suppress ferroptosis while enhancing antioxidant pathways. These findings reveal a novel mechanistic axis for CGA and establish that targeting lipid peroxidation-driven ferroptosis represents a promising therapeutic strategy for asthma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
- State Key Laboratory and Institute of Elemento-Organic Chemistry, College of Chemistry, Nankai University, Tianjin 300071, China.
- State Key Laboratory for Fine Exploration and Intelligent Development of Coal Resources, School of Chemical and Environmental Engineering, China University of Mining and Technology-Beijing, Beijing 100083, China.
- Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
- Xinjiang Key Laboratory for Uighur Medicine, Xinjiang Institute of Material Medica, Urumqi 830004, China.
ORCID-Profile: Lu-Lu Wang
Förderung
- Basic research business fund project of public welfare research institutes in Xinjiang Uygur Autonomous Region
- Fundamental Research Funds for the Central Universities
- Major Consulting Project of the Chinese Academy of Engineering
- the Major Consulting Project of the Chinese Academy of Engineering
Zitieren
APA
Zhou, P., Abudukeremu, G., Zhang, Z. L., Xu, J. Y., Ji, J. X., Guo, Y. D., Zhang, M. X., Ren, L., Wang, L. L., Tang, Z. C., Wotan, A., Rong, X. J., Tie, C., & Gao, T. L. (2026). Chlorogenic Acid Alleviates Experimental Asthma by Reprogramming DHA Metabolism to Inhibit Ferroptosis. International Journal of Molecular Sciences, 27(11), 4747. https://doi.org/10.3390/ijms27114747
Vancouver
Zhou P, Abudukeremu G, Zhang ZL, Xu JY, Ji JX, Guo YD, et al. Chlorogenic Acid Alleviates Experimental Asthma by Reprogramming DHA Metabolism to Inhibit Ferroptosis. International Journal of Molecular Sciences. 2026;27(11):4747. doi:10.3390/ijms27114747
BibTeX
@article{Zhou2026,
author = {Zhou, Ping and Abudukeremu, Gulimire and Zhang, Zhi-Li and Xu, Jing-Yi and Ji, Jian-Xuan and Guo, Yun-Dan and Zhang, Ming-Xuan and Ren, Ling and Wang, Lu-Lu and Tang, Zhi-Cheng and Wotan, Ayidana and Rong, Xiao-Juan and Tie, Cai and Gao, Tian-Le},
title = {Chlorogenic Acid Alleviates Experimental Asthma by Reprogramming DHA Metabolism to Inhibit Ferroptosis},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {11},
pages = {4747},
doi = {10.3390/ijms27114747}
}
EUVIMED